Mathews Leya, Appukuttan Devapriya, Victor Dhayanand John, Venkadassalapathy Santhosh, Subramanian Sangeetha, Prakash P S G
Postgraduate Student, Department of Periodontics, SRM Dental College, Bharathi Salai, Chennai, India.
Professor, Department of Periodontics, SRM Dental College, Bharathi Salai,Chennai, India.
Hum Immunol. 2025 Jan;86(1):111214. doi: 10.1016/j.humimm.2024.111214. Epub 2024 Dec 12.
To evaluate the role of miR-155 in macrophage polarisation in stage III/IV periodontitis with Type 2 diabetes mellitus (T2DM).
Sixty four patients were recruited and categorized into Group I-systemically and Periodontally healthy (n = 16), Group II-systemically healthy with Stage III/IV Periodontitis(n = 16), Group III-Periodontally healthy with T2DM (n = 16) and Group IV- Stage III/IV Periodontitis with T2DM(n = 16).Gingival tissue samples were collected and Real time-PCR was carried out for microRNA-155, TNF- α(marker for M1 phenotype) and Arg-1(marker for M2 phenotype) gene expression.
Group IV showed the highest increase in miR-155 fold change (FC) (11.17 ± 10.44), followed by groups III and II(10.35 ± 15.87, 5.1 ± 5.17 respectively) when compared to Group I. Likewise, the highest FC for TNF-α expression was observed in the group IV (10.11 ± 12.14). Groups II and III showed an almost similar increase in the FC(4.36 ± 4.48 and 4.79 ± 6.91, respectively). Periodontally healthy subjects demonstrated higher levels of Arg-1 gene expression(4.41 ± 5.17), followed by reduced expression in the groups II and IV (2.46 ± 2.21 and 2.65 ± 3.25, respectively). The TNF-α:Arg-1 ratio indicated that group I had higher Arg-1 expression, while group III and IV individuals had higher TNF-α expression. Compared to miR-155 and Arg-1, which demonstrated poor Area under the curve(AUC), sensitivity and specificity, TNF-α was able to distinguish between the groups III & IV (AUC = 0.74, p = 0.02, sensitivity 92 %, specificity 83 %, cut off = 27.28) and I & IV (AUC = 0.6, p = 0.03, sensitivity 81 %, specificity 77 %, cut off = 26.04).
Dysregulated miR-155 contributes to hyperinflammatory state in T2DM associated periodontitis by favouring macrophage polarisation towards the M1 phenotype.However, the strength of this relationship and the association with severity of periodontal disease could not be confirmed in this study.
评估miR-155在2型糖尿病(T2DM)伴发的III/IV期牙周炎中巨噬细胞极化过程中的作用。
招募64例患者,分为四组:I组——全身及牙周均健康(n = 16);II组——全身健康但患有III/IV期牙周炎(n = 16);III组——牙周健康但患有T2DM(n = 16);IV组——患有III/IV期牙周炎且伴有T2DM(n = 16)。采集牙龈组织样本,采用实时定量聚合酶链反应检测微小RNA-155、肿瘤坏死因子-α(M1表型标志物)和精氨酸酶-1(M2表型标志物)基因的表达。
与I组相比,IV组miR-155的倍数变化(FC)增加最多(11.17 ± 10.44),其次是III组和II组(分别为10.35 ± 15.87、5.1 ± 5.17)。同样,IV组肿瘤坏死因子-α表达的FC最高(10.11 ± 12.14)。II组和III组的FC增加幅度相近(分别为4.36 ± 4.48和4.79 ± 6.91)。牙周健康受试者精氨酸酶-1基因表达水平较高(4.41 ± 5.17),II组和IV组表达水平降低(分别为2.46 ± 2.21和2.65 ± 3.25)。肿瘤坏死因子-α与精氨酸酶-1的比值表明,I组精氨酸酶-1表达较高,而III组和IV组个体肿瘤坏死因子-α表达较高。与miR-155和精氨酸酶-1相比,其曲线下面积(AUC)、敏感性和特异性较差,肿瘤坏死因子-α能够区分III组与IV组(AUC = 0.74,p = 0.02,敏感性92%,特异性83%,截断值 = 27.28)以及I组与IV组(AUC = 0.6,p = 0.03,敏感性81%,特异性77%,截断值 = 26.04)。
miR-155失调通过促使巨噬细胞向M1表型极化,导致T2DM相关性牙周炎的炎症状态增强。然而,本研究未能证实这种关系的强度以及与牙周疾病严重程度的关联。